Crosstalk between BPA and FXRα Signaling Pathways Lead to Alterations of Undifferentiated Germ Cell Homeostasis and Male Fertility Disorders

• Published in: Stem cell reports 2018-10, Vol.11 (4), p.944-958
• Main Authors: Sèdes, Lauriane, Desdoits-Lethimonier, Christèle, Rouaisnel, Betty, Holota, Hélène, Thirouard, Laura, Lesne, Laurianne, Damon-Soubeyrand, Christelle, Martinot, Emmanuelle, Saru, Jean-Paul, Mazaud-Guittot, Séverine, Caira, Françoise, Beaudoin, Claude, Jégou, Bernard, Volle, David H.
• Format: Article
• Language: English
• Subjects: bisphenol-A; Ecology, environment; Ecotoxicology; fertility; FXRα; germ cell; Health; Life Sciences; Reproductive Biology; testis; Toxicology
• ISSN: 2213-6711; 2213-6711
• DOI: 10.1016/j.stemcr.2018.08.018

Several studies have reported an association between the farnesoid X receptor alpha (FXRα) and estrogenic signaling pathways. Fxrα could thus be involved in the reprotoxic effects of endocrine disruptors such as bisphenol-A (BPA). To test this hypothesis, mice were exposed to BPA and/or stigmasterol (S), an FXRα antagonist. Following the exposure to both molecules, wild-type animals showed impaired fertility and lower sperm cell production associated with the alteration of the establishment and maintenance of the undifferentiated germ cell pool. The crosstalk between BPA and FXRα is further supported by the lower impact of BPA in mice genetically ablated for Fxrα and the fact that BPA counteracted the effects of FXRα agonists. These effects might result from the downregulation of Fxrα expression following BPA exposure. BPA and S act additively in human testis. Our data demonstrate that FXRα activity modulates the impact of BPA on male gonads and on undifferentiated germ cell population. •BPA and S exposures synergistically induce male fertility disorders•BPA regulates Fxr expression•BPA and S act additively in human testis In this article, Dr Volle and colleagues show that Fxrα participate in the reprotoxic effects of endocrine disruptors such as bisphenol-A (BPA). The present study shows that modulation of FXRa signaling pathway by the FXRα antagonist, namely stigmasterol, acts additively with BPA, leading to impaired fertility and lower sperm cell production associated with the alteration of the establishment and maintenance of the undifferentiated germ cell pool. In addition these additive effects were also observed in human testis.